Daiichi Sankyo
Carter Tremayne is an accomplished finance professional with extensive experience in the pharmaceutical and healthcare industries. Currently serving as the Executive Director and Global Head of Asset & Portfolio Management Finance at Daiichi Sankyo, Carter oversees the Financial Analysis & Budget Management group, playing a key role in the R&D budget development process and participating in high-level finance committees. As a Co-Founder, Vice Chair of the Board, and Treasurer of The Bloom Foundation, Carter champions awareness of Perinatal Mood and Anxiety Disorders. Previous roles include independent consultant at Replogix LLC, Controller at Cordis, and various finance positions at Johnson & Johnson, where significant contributions to R&D budget management and financial analysis were made. Carter holds a BS in Accounting from Wilkes University.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.